(NIH/National Institute of Neurological Disorders and Stroke) The Network for Excellence in Neuroscience Clinical Trials, or NeuroNEXT, a research program that helps streamline Phase II clinical trials for brain disorders, has been renewed for five more years, with several new centers joining the program. NeuroNEXT is supported by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health.
from EurekAlert! - Social and Behavioral Science https://ift.tt/2uXaTYM
No comments:
Post a Comment